PLUR Form 10-K: Annual report

Pluri Inc. Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2026-09-10: Form 10-K; Period of report 2026-06-30; Description ANNUAL REPORT; Document ea0304639-10k_pluri.htm.
2025-09-17: Form 10-K; Period of report 2025-06-30; Description ANNUAL REPORT; Document ea0256130-10k_pluriinc.htm.
2024-09-18: Form 10-K; Period of report 2024-06-30; Description ANNUAL REPORT; Document ea0213910-10k_pluriinc.htm.
2023-09-12: Form 10-K; Period of report 2023-06-30; Description ANNUAL REPORT; Document f10k2023_pluriinc.htm.

Filed	Form	Period of report	Description	Document
2026-09-10	10-K	2026-06-30	ANNUAL REPORT	ea0304639-10k_pluri.htm
2025-09-17	10-K	2025-06-30	ANNUAL REPORT	ea0256130-10k_pluriinc.htm
2024-09-18	10-K	2024-06-30	ANNUAL REPORT	ea0213910-10k_pluriinc.htm
2023-09-12	10-K	2023-06-30	ANNUAL REPORT	f10k2023_pluriinc.htm
2022-09-21	10-K	2022-06-30	ANNUAL REPORT	f10k2022_pluriinc.htm
2021-09-13	10-K	2021-06-30	ANNUAL REPORT	f10k2021_pluristemtherap.htm
2020-09-10	10-K	2020-06-30	ANNUAL REPORT	f10k2020_pluristemtherap.htm
2019-09-12	10-K	2019-06-30	ANNUAL REPORT	f10k2019_pluristemtherap.htm
2018-09-12	10-K	2018-06-30	10-K	zk1822069.htm
2017-09-07	10-K	2017-06-30	10-K	zk1720512.htm
2016-09-07	10-K	2016-06-30	10-K	zk1618969.htm
2015-09-09	10-K	2015-06-30	10-K	zk1517290.htm
2014-09-11	10-K	2014-06-30	10-K	zk1415514.htm
2013-09-11	10-K	2013-06-30	10-K	zk1313616.htm
2012-09-10	10-K	2012-06-30	10-K	zk1211927.htm
2011-09-12	10-K	2011-06-30	10-K	zk1110396.htm
2010-09-21	10-K	2010-06-30	10-K	zk1008800.htm
2009-09-23	10-K	2009-06-30	Annual report	zk97278.htm
2008-09-29	10-K	2008-06-30	Annual report	zk85861.htm

Stock Name	Country	Market Cap	PE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)	United States	$0.013B	-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)	United States	$0.013B	-1.05
Passage BIO, Inc. (PASG)	United States	$0.015B	-0.43
IN8BIO, INC. (INAB)	United States	$0.012B	-0.76
DYADIC INTERNATIONAL INC (DYAI)	United States	$0.016B
BioCardia, Inc. (BCDA)	United States	$0.016B
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37
CERO THERAPEUTICS HOLDINGS, INC. (CERO)	United States	$0.007B